In addition, we found that nPAK4-ERα axis contributes to breast-to-bone metastasis in ERα+ breast cancer via antagonizing the activity of a breast cancer bone metastasis suppressor, leukemia inhibitory factor receptor (LIFR) [18, 19]. The gene discussed is LIFR; the disease is breast carcinoma.